Many states, looking to rein in the cost of expensive anti-psychotic drugs such as Zyprexa, have turned to an unusual ally for helpthe very company that sells the drug. At more than $300 for a monthly prescription, Zyprexa, which is used to treat schizophrenia and bipolar disorder, is the single biggest drug cost for state Medicaid budgets. So Eli Lilly and Co., the maker of Zyprexa, offers to help states monitor doctors who treat Medicaid patients to make sure they are not wasting money because of sloppy prescribing. FULL STORY
In some states, maker oversees use of its drug
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.